SALBUTAMOL CIPLA salbutamol 2.5mg/2.5mL (as sulfate) inhalation ampoules - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
SALBUTAMOL CIPLA salbutamol 2.5mg/2.5mL (as sulfate) inhalation ampoules
AUST R: 115652
Active ingredients:
salbutamol sulfate

Dosage form:
Inhalation, conventional

Sponsor:
Cipla Australia Pty Ltd

Phone:
0396964413

Deletion from market:
24 Jun 2026

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals